M. D. Altıntop Et Al. , "Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy," EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.276, 2024
Altıntop, M. D. Et Al. 2024. Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.276 .
Altıntop, M. D., Ertorun, I., Ciftci, G. A., & Özdemir, A., (2024). Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.276.
Altıntop, MEHLİKA Et Al. "Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy," EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.276, 2024
Altıntop, MEHLİKA D. Et Al. "Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy." EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.276, 2024
Altıntop, M. D. Et Al. (2024) . "Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy." EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.276.
@article{article, author={MEHLİKA DİLEK ALTINTOP Et Al. }, title={Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy}, journal={EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY}, year=2024}